FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections
Two Japanese drugmakers and another in India were hit with Form 483s from the FDA following inspections that uncovered issues
Continue Reading
Latest
Cancer Medicines to Become Cheaper After Pakistan’s 2026 Budget |
Pakistan Removes Tax on Sanitary Pads to Fight Period Poverty |
Pakistan Removes Tax on Contraceptives to Boost Family Planning |
Tea Benefits Explained: Why Brewing Matters for Your Health |
Government Relaunches Sehat Sahulat Program in Islamabad |
June 13, 2026